HIV/AIDS Seroconversion
Some seroconverters can control HIV viremia spontaneously
Published in AIDS Weekly, February 20th, 2006
In a recently published report from England, investigators conducted a study to "identify factors associated with sustained undetectable viremia after HIV-1 seroconversion in treatment-naive patients, and to describe concomitant CD4 cell count progression."
"Seroconverters enrolled in CASCADE were assumed to control viremia if at least two consecutive viral load measurements were <400/500 copies/ml without treatment. Factors associated with undetectable viremia were identified through a logistic regression.
"A joint model was used to describe simultaneously the CD4 cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-02-20)
More Articles from AIDS Weekly
- Disease Associations
High prevalence of HPV infections in urine samples from HIV-infected men - HIV/AIDS HAART
HIV protease mutations predict virological response to lopinavir and ritonavir - HIV/AIDS HAART
Some patients have less rapid relative decline in AIDS incidence in first year on HAART - HIV/AIDS Screening
HIV ELISA kits for antibody screening have variable sensitivity and specificity - Antiviral Therapy
Antiretroviral therapy response may be altered in HCV antibody-positive HIV-infected patients - Blood Safety
South African program associated with decline in HIV-1 in blood donations - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
